Cost effectiveness

Bioregional planning in central Georgia, USA

Land management / Economic Development / Air pollution / Multidisciplinary / Regional Planning / Urban Growth / Models / Environmental Concern / Ecosystems / Land Use / Futures / Longleaf Pine / Growth and development / Forests / Environmental protection / Cost effectiveness / Habitats / Environmental Impact / Noise Pollution / Pinus palustris / Environmental Conditions / Ecosystem service / Urban Growth / Models / Environmental Concern / Ecosystems / Land Use / Futures / Longleaf Pine / Growth and development / Forests / Environmental protection / Cost effectiveness / Habitats / Environmental Impact / Noise Pollution / Pinus palustris / Environmental Conditions / Ecosystem service

Dislipidemias: un reto pendiente en prevención cardiovascular. Documento de consenso CEIPC/SEA

Decision Making / Physical Activity / Cardiovascular disease / Cardiovascular Risk / Spain / Humans / Smoking Cessation / Female / Male / Cost effectiveness / Risk factors / Cardiovascular Diseases / Risk Factors / Medicina Clinica / Humans / Smoking Cessation / Female / Male / Cost effectiveness / Risk factors / Cardiovascular Diseases / Risk Factors / Medicina Clinica

Modeling obsolete computer stock under regional data constraints: An Atlanta case study

Engineering / Regional development / Environmental Sciences / Case Study / Research Excellence Framework / Cost effectiveness / Energy and Material Flow Analysis / Economic Benefit / Cost effectiveness / Energy and Material Flow Analysis / Economic Benefit

Familial hypercholesterolaemia: a model of care for Australasia

Atherosclerosis / Adolescent / Humans / Child / Genetic Testing / Female / New Zealand / Standardisation / Expert Opinion / Australasia / Cost effectiveness / Risk factors / Spectrum / Adult / Coronary heart disease / Risk Factors / Female / New Zealand / Standardisation / Expert Opinion / Australasia / Cost effectiveness / Risk factors / Spectrum / Adult / Coronary heart disease / Risk Factors

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Thoracoscopic Transmyocardial Laser Revascularization

Carbon Dioxide / Endoscopy / Video Analysis / Humans / Left Ventricular Assist Device / Female / Animals / Feasibility Studies / Male / Follow-up studies / Cost effectiveness / Myocardial Revascularization / Clinical Sciences / Aged / Myocardium / Coronary heart disease / Clinical Data / Swine / Angina pectoris / SURGICAL TECHNIQUE / Laser Therapy / Ischemic Heart Disease / Coronary Artery Disease / Pericardium / Thoracoscopy / Female / Animals / Feasibility Studies / Male / Follow-up studies / Cost effectiveness / Myocardial Revascularization / Clinical Sciences / Aged / Myocardium / Coronary heart disease / Clinical Data / Swine / Angina pectoris / SURGICAL TECHNIQUE / Laser Therapy / Ischemic Heart Disease / Coronary Artery Disease / Pericardium / Thoracoscopy

Cardiología del adulto-Trabajos libres

Arterial hypertension / Pulmonary Hypertension / Google / Heart Failure / Electrical Resistance / Cost effectiveness / Impedance cardiography / Cardiologia / Cardiac Output Monitoring / Fractal Dimension / Cardiac-Resynchronization-Therapy-Devices-Market / Minimally Invasive / Cost effectiveness / Impedance cardiography / Cardiologia / Cardiac Output Monitoring / Fractal Dimension / Cardiac-Resynchronization-Therapy-Devices-Market / Minimally Invasive

CARDIOLOGÍA DEL ADULTO - TRABAJOS LIBRES

Arterial hypertension / Pulmonary Hypertension / Google / Heart Failure / Electrical Resistance / Cost effectiveness / Impedance cardiography / Cardiologia / Cardiac Output Monitoring / Fractal Dimension / Cardiac-Resynchronization-Therapy-Devices-Market / Minimally Invasive / Cost effectiveness / Impedance cardiography / Cardiologia / Cardiac Output Monitoring / Fractal Dimension / Cardiac-Resynchronization-Therapy-Devices-Market / Minimally Invasive

Seven days or ten? Cost-effectiveness study on the duration of H pylori treatment in primary care | ¿Siete o diez días? Estudio de coste-efectividad sobre la duración del tratamiento de la infección por H. pylori en atención primaria

Primary Care / Treatment / Helicobacter pylori / Cost effectiveness / Clinical Sciences / Atencion Primaria De La Salud / H Pylori / Atencion Primaria De La Salud / H Pylori

Viral population estimation using pyrosequencing

Algorithms / Immune response / HIV / Biological Sciences / Population structure / Sequence alignment / Mathematical Sciences / Drug Resistance / EM algorithm / Cost effectiveness / Disease Control / Error Correction / Evolutionary Dynamics / Expectation Maximization / Drug Therapy / Genetic variation / Statistical Model / Base Sequence / Computational Method / Statistical Approach / Molecular Sequence Data / Sequence alignment / Mathematical Sciences / Drug Resistance / EM algorithm / Cost effectiveness / Disease Control / Error Correction / Evolutionary Dynamics / Expectation Maximization / Drug Therapy / Genetic variation / Statistical Model / Base Sequence / Computational Method / Statistical Approach / Molecular Sequence Data

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2013 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Bioregional planning in central Georgia, USA

Land management / Air pollution / Multidisciplinary / Urban Growth / Environmental Concern / Futures / Longleaf Pine / Growth and development / Environmental protection / Cost effectiveness / Noise Pollution / Pinus palustris / Environmental Conditions / Ecosystem service / Futures / Longleaf Pine / Growth and development / Environmental protection / Cost effectiveness / Noise Pollution / Pinus palustris / Environmental Conditions / Ecosystem service
Copyright © 2017 DATOSPDF Inc.